| ACKNOWLEDGEMENTS | 第4-5页 |
| ABSTRACT | 第5页 |
| 摘要 | 第6-7页 |
| LIST OF ABBREVIATIONS | 第7-16页 |
| 1. INTRODUCTION | 第16-19页 |
| 1.1 Background | 第16-17页 |
| 1.2 Research Purpose and Signification | 第17-18页 |
| 1.3 Methodology | 第18-19页 |
| 2. LITERATURE REVIEW | 第19-34页 |
| 2.1 International and China’s Research Status of Internet Medical Service | 第19-27页 |
| 2.1.1 China’s Research Status of Internet Medical Service | 第19-23页 |
| 2.1.2 American Research Status of Internet Medical Service | 第23-27页 |
| 2.2 Research Status of the Internet Medical Ecosystem | 第27-29页 |
| 2.2.1 China’s Mobile Medical Market Segmentation | 第27-28页 |
| 2.2.2 Figure of Reconstruction of Relationship among Patients, Doctors,Hospitals and Pharmacies | 第28页 |
| 2.2.3 The Industrial Chain of Pharmaceutical Production, Procurement andSales Reconstructed by the Medical E-supplier Platform | 第28-29页 |
| 2.3 Research Framework | 第29-34页 |
| 2.3.1 The Inside Track of the Internet Medical Ecosystem | 第30-31页 |
| 2.3.2 The Outside Track of the Internet Medical Ecosystem | 第31-32页 |
| 2.3.3 Combined Tracks of the Internet Medical Ecosystem | 第32-34页 |
| 3. CASE DESCRIPTION | 第34-53页 |
| 3.1 Introduction to A Company | 第34-39页 |
| 3.2 The Status and Problems of Public Hospitals faced by A Company | 第39-46页 |
| 3.3 Current Situation of the Construction of Medical Ecosystem of A Company | 第46-49页 |
| 3.4 Future Challenges and Development Trends of A Company | 第49-53页 |
| 3.4.1 Growing Online Demands in Direct Billing Hospitals | 第49-50页 |
| 3.4.2 Required Costs-reducing Control on Medical Expenditure | 第50-51页 |
| 3.4.3 Required Actuarial and Data Supports | 第51-53页 |
| 4. CASE ANALYSIS | 第53-74页 |
| 4.1 Corporate Environment Analysis of A Company | 第53-62页 |
| 4.1.1 PEST Analysis | 第53-59页 |
| 4.1.2 A Company Five Forces Analysis | 第59-62页 |
| 4.2 Status Quo and Problems | 第62-74页 |
| 4.2.1 A Company’s On-line Platform Problems and Client Changes | 第62-67页 |
| 4.2.2 A Company’s Medicine Supply Problems | 第67-69页 |
| 4.2.3 A Company’s Third Party Service Problems | 第69-71页 |
| 4.2.4 A Company’s Medical Provider Problems | 第71-74页 |
| 5. SUGGESTIONS | 第74-79页 |
| 5.1 Establishing Online Platform | 第74页 |
| 5.2 Improving Medicine Supply Channels | 第74-76页 |
| 5.3 Expanding the Cooperation with Third Party Service Institutions | 第76页 |
| 5.4 Reforming Medical Service Providers | 第76-79页 |
| 6. CONCLUSIONS | 第79-81页 |
| 7. IMPLICATIONS | 第81-83页 |
| REFERENCE | 第83-85页 |
